![(11β,16α)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Di…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFF103709.webp&w=3840&q=75)

(11β,16α)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Diene-3,20-Dione Disodium Sal t
CAS:
Ref. 3D-FF103709
![(11β,16α)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Di…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFF103709.webp&w=3840&q=75)

Informação sobre produto
Nome:(11β,16α)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Diene-3,20-Dione Disodium Sal t
Marca:Biosynth
Descrição:(11beta,16alpha)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Diene-3,20-Dione Disodium Sal t is a supramolecular drug that inhibits the activity of lipoxygenase. This drug has been shown to be effective in preventing the progression of age related macular degeneration by inhibiting the production of proinflammatory molecules such as leukotrienes and prostaglandins. It also minimizes cataract formation and is used in devices such as intraocular lenses. The molecular structure consists of a steroid nucleus with an annulare ring system that can be injected into tissues and cells. The molecule is bioactive and pharmacologically active when it binds to collagen or amino acids.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:558.44 g/mol
Fórmula:C24H30FNa2O9P
Pureza:Min. 95%